No association between chronic use of ranitidine, compared with omeprazole or famotidine, and gastrointestinal malignancies.
Yeseong D KimJiasheng WangFahmi ShibliKamrine E PoelsStephen J GanocyRonnie FassPublished in: Alimentary pharmacology & therapeutics (2021)
Use of ranitidine was not associated with an increased odds of developing gastrointestinal malignancies compared to omeprazole or famotidine use.
Keyphrases